RDHL
RedHill Biopharma Ltd. Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website redhillbio.com
- Employees(FY) 113
- ISIN US7574682024
Performance
+4.85%
1W
-14.52%
1M
-16.83%
3M
+29.57%
6M
-69.03%
YTD
-81.08%
1Y
Profile
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Technical Analysis of RDHL 2024-05-03
Overview:
In analyzing the technical indicators for RDHL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...
Recent News & Updates
- 2024-05-05 19:43
- 2024-05-05 19:00
- 2024-04-23 19:00
- 2024-04-07 21:23
- 2024-04-01 19:00
- 2024-03-10 19:00
- 2024-03-04 18:00
- 2024-02-19 18:00
- 2024-01-25 23:46
- 2024-01-24 20:05
- 2024-01-24 17:00
- 2023-12-19 19:45
- 2023-12-11 18:00
- 2023-12-03 18:00
- 2023-12-03 00:11
5 Most Volatile Stocks Under $5 For Day Trading(Insidermonkey)
- 2023-11-29 20:08
Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?(Investorplace)
- 2023-11-27 00:41
5 Investors Betting Big on RedHill Biopharma (RDHL) Stock(Investorplace)
- 2023-11-26 18:00
- 2023-11-13 19:00
- 2023-10-02 19:00
- 2023-09-22 04:15
- 2023-09-17 19:00
RedHill Announces FDA sNDA Approval for Talicia®(Yahoo Finance)
- 2023-09-04 19:00
- 2023-08-16 19:00
- 2023-07-31 19:00
- 2023-07-30 19:00
- 2023-07-25 03:58
- 2023-07-20 21:33
- 2023-07-20 19:00
- 2023-06-11 20:00
Page 1 of 4
previousnext